With a focus on cytokine and receptor mediated mechanisms of disease, Arakis Limited identifies, develops, and commercializes medicinal products based on established drugs and drug templates. Their research capability enables them to uncover new clinical uses for known drugs or enhance the performance of existing medicines. The company's chosen therapeutic areas are inflammatory disease and pain, where they strive to bring innovative solutions to market.